• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对抗冠状病毒策略中来自海洋生物的生物活性化合物。

Biologically active compounds from marine organisms in the strategies for combating coronaviruses.

作者信息

Zaporozhets Tatyana S, Besednova Nataliya N

机构信息

Immunology Laboratory, Somov Institute of Epidemiology and Microbiology, Vladivostok, Russian Federation.

出版信息

AIMS Microbiol. 2020 Dec 7;6(4):470-494. doi: 10.3934/microbiol.2020028. eCollection 2020.

DOI:10.3934/microbiol.2020028
PMID:33364539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7755586/
Abstract

Despite the progress made in immunization and drug development, so far there are no prophylactic vaccines and effective therapies for many viral infections, including infections caused by coronaviruses. In this regard, the search for new antiviral substances continues to be relevant, and the enormous potential of marine resources are a stimulus for the study of marine compounds with antiviral activity in experiments and clinical trials. The highly pathogenic human coronaviruses-severe acute respiratory syndrome-related coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) remain a serious threat to human health. In this review, the authors hope to bring the attention of researchers to the use of biologically active substances of marine origin as potential broad-spectrum antiviral agents targeting common cellular pathways and various stages of the life cycle of different viruses, including coronaviruses. The review has been compiled using references from major databases such as Web of Science, PubMed, Scopus, Elsevier, Springer and Google Scholar (up to June 2020) and keywords such as 'coronaviruses', 'marine organisms', 'biologically active substances', 'antiviral drugs', 'SARS-CoV', 'MERS-CoV', 'SARS-CoV-2', '3CLpro', 'TMPRSS2', 'ACE2'. After obtaining all reports from the databases, the papers were carefully analysed in order to find data related to the topic of this review (98 references). Biologically active substances of marine origin, such as flavonoids, phlorotannins, alkaloids, terpenoids, peptides, lectins, polysaccharides, lipids and others substances, can affect coronaviruses at the stages of penetration and entry of the viral particle into the cell, replication of the viral nucleic acid and release of the virion from the cell; they also can act on the host's cellular targets. These natural compounds could be a vital resource in the fight against coronaviruses.

摘要

尽管在免疫接种和药物研发方面取得了进展,但到目前为止,对于许多病毒感染,包括由冠状病毒引起的感染,仍没有预防性疫苗和有效的治疗方法。在这方面,寻找新的抗病毒物质仍然具有现实意义,海洋资源的巨大潜力促使人们在实验和临床试验中研究具有抗病毒活性的海洋化合物。高致病性人类冠状病毒——严重急性呼吸综合征相关冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)、严重急性呼吸综合征相关冠状病毒2(SARS-CoV-2)仍然对人类健康构成严重威胁。在这篇综述中,作者希望引起研究人员对海洋来源生物活性物质的关注,这些物质作为潜在的广谱抗病毒剂,可针对常见的细胞途径以及包括冠状病毒在内的不同病毒生命周期的各个阶段发挥作用。这篇综述使用了来自科学网、PubMed、Scopus、爱思唯尔、施普林格和谷歌学术等主要数据库(截至2020年6月)的参考文献,以及“冠状病毒”、“海洋生物”、“生物活性物质”、“抗病毒药物”、“SARS-CoV”、“MERS-CoV”、“SARS-CoV-2”、“3CLpro”、“TMPRSS2”、“ACE2”等关键词进行编写。从数据库获取所有报告后,对论文进行了仔细分析,以找到与本综述主题相关的数据(98篇参考文献)。海洋来源的生物活性物质,如黄酮类化合物、褐藻多酚、生物碱、萜类化合物、肽、凝集素、多糖、脂质和其他物质,可在病毒颗粒穿透和进入细胞、病毒核酸复制以及病毒粒子从细胞释放等阶段影响冠状病毒;它们还可作用于宿主细胞靶点。这些天然化合物可能是对抗冠状病毒的重要资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c40c/7755586/bd5b80e728ac/microbiol-06-04-028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c40c/7755586/bd5b80e728ac/microbiol-06-04-028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c40c/7755586/bd5b80e728ac/microbiol-06-04-028-g001.jpg

相似文献

1
Biologically active compounds from marine organisms in the strategies for combating coronaviruses.对抗冠状病毒策略中来自海洋生物的生物活性化合物。
AIMS Microbiol. 2020 Dec 7;6(4):470-494. doi: 10.3934/microbiol.2020028. eCollection 2020.
2
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
3
Multifaceted role of natural sources for COVID-19 pandemic as marine drugs.天然产物在新冠疫情中的多面角色——海洋药物。
Environ Sci Pollut Res Int. 2022 Jul;29(31):46527-46550. doi: 10.1007/s11356-022-20328-5. Epub 2022 May 4.
4
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.严重急性呼吸综合征冠状病毒木瓜样蛋白酶:结构、功能及设计的抗病毒化合物对其的抑制作用
Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29.
5
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.在动物模型中,通过治疗给药,有效的 3CLpro 抑制剂对 SARS-CoV-2 和 MERS-CoV 有效。
mBio. 2024 Feb 14;15(2):e0287823. doi: 10.1128/mbio.02878-23. Epub 2023 Dec 21.
6
Broad-spectrum coronavirus antiviral drug discovery.广谱冠状病毒抗病毒药物的发现。
Expert Opin Drug Discov. 2019 Apr;14(4):397-412. doi: 10.1080/17460441.2019.1581171. Epub 2019 Mar 8.
7
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.阿贝尔森激酶抑制剂是严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒融合的强效抑制剂。
J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1.
8
A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2.植物源人冠状病毒天然抑制剂的机制研究综述,重点关注 SARS-CoV-1 和 SARS-CoV-2。
Curr Drug Targets. 2022;23(8):818-835. doi: 10.2174/1389450122666211005115313.
9
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
10
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.紫锥菊制剂 Echinaforce®抗冠状病毒(包括普通感冒冠状病毒 229E 和 SARS-CoV-2)的体外病毒杀灭活性。
Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2.

引用本文的文献

1
Analyzing energetics and dynamics of hepatitis C virus polymerase interactions with marine bacterial compounds: a computational study.丙型肝炎病毒聚合酶与海洋细菌化合物相互作用的能量学和动力学分析:一项计算研究。
Mol Divers. 2025 Apr;29(2):1245-1260. doi: 10.1007/s11030-024-10904-x. Epub 2024 Jun 10.
2
Marine-Derived Bioactive Metabolites as a Potential Therapeutic Intervention in Managing Viral Diseases: Insights from the SARS-CoV-2 In Silico and Pre-Clinical Studies.海洋来源的生物活性代谢产物作为治疗病毒性疾病的潜在干预措施:来自SARS-CoV-2计算机模拟和临床前研究的见解
Pharmaceuticals (Basel). 2024 Mar 1;17(3):328. doi: 10.3390/ph17030328.
3

本文引用的文献

1
Natural products' role against COVID-19.天然产物在抗击新冠病毒中的作用。
RSC Adv. 2020 Jun 19;10(39):23379-23393. doi: 10.1039/d0ra03774e. eCollection 2020 Jun 16.
2
Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic.筛选临床前和临床研究中的天然和衍生生物活性化合物:抗击冠状病毒大流行的前沿之一。
Phytomedicine. 2021 May;85:153311. doi: 10.1016/j.phymed.2020.153311. Epub 2020 Aug 29.
3
Bioactive natural compounds against human coronaviruses: a review and perspective.
Marine Alga -Derived Molecules for the Potential Treatment of SARS-CoV-2: An Approach.
海洋藻类来源的分子用于 SARS-CoV-2 的潜在治疗:一种方法。
Mar Drugs. 2022 Sep 19;20(9):586. doi: 10.3390/md20090586.
4
Multifaceted role of natural sources for COVID-19 pandemic as marine drugs.天然产物在新冠疫情中的多面角色——海洋药物。
Environ Sci Pollut Res Int. 2022 Jul;29(31):46527-46550. doi: 10.1007/s11356-022-20328-5. Epub 2022 May 4.
5
Recent Progress in Antioxidant Active Substances from Marine Biota.海洋生物抗氧化活性物质的研究进展
Antioxidants (Basel). 2022 Feb 22;11(3):439. doi: 10.3390/antiox11030439.
6
Impact of novel microbial secondary metabolites on the pharma industry.新型微生物次生代谢产物对制药行业的影响。
Appl Microbiol Biotechnol. 2022 Mar;106(5-6):1855-1878. doi: 10.1007/s00253-022-11821-5. Epub 2022 Feb 21.
7
Potential bioactive compounds as SARS-CoV-2 inhibitors from extracts of the marine red alga (Rhodophyta) - A computational study.从海洋红藻(红藻门)提取物中筛选潜在的具有抗SARS-CoV-2活性的生物活性化合物——一项计算研究
Arab J Chem. 2021 Nov;14(11):103393. doi: 10.1016/j.arabjc.2021.103393. Epub 2021 Aug 23.
8
Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.基于对接的虚拟筛选及从褐藻中鉴定潜在的新冠病毒主要蛋白酶抑制剂
S Afr J Bot. 2021 Dec;143:428-434. doi: 10.1016/j.sajb.2021.06.033. Epub 2021 Jul 1.
9
The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19.海藻硫酸多糖纠正 COVID-19 出血障碍的效力。
Molecules. 2021 Apr 29;26(9):2618. doi: 10.3390/molecules26092618.
10
Antifungal and Larvicidal Activities of Phlorotannins from Brown Seaweeds.褐藻多酚的抗真菌和杀幼虫活性。
Mar Drugs. 2021 Apr 16;19(4):223. doi: 10.3390/md19040223.
抗人类冠状病毒的生物活性天然化合物:综述与展望
Acta Pharm Sin B. 2020 Jul;10(7):1163-1174. doi: 10.1016/j.apsb.2020.06.002. Epub 2020 Jun 8.
4
Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibition: an analysis.植物源天然多酚类化合物作为抗 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp)抑制剂的潜在抗病毒药物:分析。
J Biomol Struct Dyn. 2021 Oct;39(16):6249-6264. doi: 10.1080/07391102.2020.1796810. Epub 2020 Jul 28.
5
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.硫酸化多糖在体外能有效抑制新型冠状病毒。
Cell Discov. 2020 Jul 24;6(1):50. doi: 10.1038/s41421-020-00192-8. eCollection 2020.
6
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.肝素与严重急性呼吸综合征相关冠状病毒 2(SARS-CoV-2)刺突糖蛋白结合相互作用的表征。
Antiviral Res. 2020 Sep;181:104873. doi: 10.1016/j.antiviral.2020.104873. Epub 2020 Jul 10.
7
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors.冠状病毒 3C 样蛋白酶抑制剂在开发新型抗 SARS-CoV-2 药物中的潜力:来自蛋白酶和抑制剂结构的见解。
Int J Antimicrob Agents. 2020 Aug;56(2):106055. doi: 10.1016/j.ijantimicag.2020.106055. Epub 2020 Jun 11.
8
In silico evaluation of marine fish proteins as nutritional supplements for COVID-19 patients.海洋鱼类蛋白作为 COVID-19 患者营养补充剂的计算机评估。
Food Funct. 2020 Jun 24;11(6):5565-5572. doi: 10.1039/d0fo00530d.
9
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.组织蛋白酶 L 选择性抑制剂:COVID-19 患者的一种有前途的治疗方法。
Pharmacol Ther. 2020 Sep;213:107587. doi: 10.1016/j.pharmthera.2020.107587. Epub 2020 May 26.
10
Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study.海洋天然化合物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶的有效抑制剂——一项分子动力学研究
J Biomol Struct Dyn. 2021 Jul;39(10):3627-3637. doi: 10.1080/07391102.2020.1769733. Epub 2020 Jun 1.